Oligonucleotide therapeutics may stop this pandemic, and that's our top priority right now. But we also want to accelerate their development to treat ultra-rare diseases. Here's our plan.
We are excited to share STOPCovid, an inexpensive, one-step, & sensitive #COVID-19 detection protocol developed with @omarabudayyeh & @jgooten. This revamped assay was streamlined with the future goal of developing an in-home test for COVID-19. https://t.co/AhGrm6NYvz 1/X